4//SEC Filing
Floyd Robert Michael 4
Accession 0001567619-21-013195
CIK 0001533743other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:47 PM ET
Size
10.0 KB
Accession
0001567619-21-013195
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2021-07-08+12,858→ 12,858 totalExercise: $0.00→ Common Stock (12,858 underlying) - Award
Restricted Stock Units
2021-07-08+8,572→ 8,572 totalExercise: $0.00→ Common Stock (8,572 underlying) - Award
Restricted Stock Units
2021-07-08+1,907→ 10,034 totalExercise: $0.00→ Common Stock (10,034 underlying)
Footnotes (3)
- [F1]The restricted stock units vest in two equal installments beginning July 1, 2022.
- [F2]The Restricted Stock Units vest upon achievement of certain performance goals.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001828217
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:47 PM ET
- Size
- 10.0 KB